198HO02194 GEYSER P

Print/PDF
Registration Name TIRSVAD HOTSPOT GEYSER-ET
Registration Number HODNK002371403162
Primary NAAB Code 198HO02194
Secondary Code(s) 598HO02194
Status Inactive
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 2/18/2019
aAa 234165
DMS -
GFI 12.2%
Genetic Codes * TL TV TY PC TC TR TD TM TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HHP-C
Sire WILDER HOTSPOT P-ET
MGS DG KINGBOY SNIPER-ET
Beta Casein A1A2
Kappa Casein BE
Beta Lactoglobulin AA
INDEXES
NM$ 102, 84% R CM$ 127
NM Percentile 20% FM$ 52
GTPI 2806 GM$ 156
PRODUCTION TRAITS
3027 Dtrs 465 herds 0 % US 92% R
Milk -191 Fat, % -35 , -0.10%
SCS 2.54, 92% R Protein, % 5 , +0.04%
Feed Saved -71 , 54% R Milking Speed 6.62 , 64% R
Health & Fertility
Productive Life 4.1      89% R Mastitis 4.7      78% R
Heifer Livability 0.2       53% R Metritis 1.3      69% R
Livability 2.0      82% R D. Abom -0.2      72% R
DPR 4.5      90% R Ketosis 1.1      69% R
FSC 14.4      77% R R. Placenta 0.1      70% R
HCR 3.6      88% R Milk Fever -0.1      62% R
CCR 6.6      89% R
SCR -        -
DIA 0.4      40% R
RSP -0.2      48% R
Calving Traits
Sire CE 1.1      70% R 1608 Obs
Daughter CE 1.4      56% R 0 Obs, 1211 Dtrs
Sire SB 3.6      46% R 3046 Obs
Daughter SB 4.1      57% R 0 Obs, Dtrs
Gestation Length 1.9      77% R 0 Obs, 0 Dtrs
Early First Calving -0.3      75% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
0 Dtrs 0 herds 90% R
PTA Type 0.61 UDC 1.28
HCC 0.14 BWC 0.09
FLC 0.64
Linear Traits
Stature 0.79
Tall
Strength -0.61
Strong
Body Depth -0.57
Shallow
Dairy Form -0.80
Closed
Rump Angle -1.04
Flat
Thurl Width 0.08
Flat
Rear Legs-Side View 0.08
Wide
Rear Legs-Rear View 1.03
Straight
Foot Angle 0.78
Steep
Feet & Legs Score 0.75
High
F.U. Attachment -1.69
Straight
Rear Udder Height 1.65
High
Rear Udder Width 1.02
Wide
Udder Cleft -0.50
Weak
Udder Depth 1.03
Straight
Front Teat Placement -1.12
Wide
Rear Teat Placement -2.04
Wide
Teat Length -0.08
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO